• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲癌症研究与治疗组织(EORTC)的正电子发射断层扫描(PET)反应标准比实体瘤疗效评价标准(PERCIST)更容易受到重建不一致性的影响,但两者都受益于欧洲放射学会低剂量协议(EARL)协调计划。

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.

作者信息

Lasnon Charline, Quak Elske, Le Roux Pierre-Yves, Robin Philippe, Hofman Michael S, Bourhis David, Callahan Jason, Binns David S, Desmonts Cédric, Salaun Pierre-Yves, Hicks Rodney J, Aide Nicolas

机构信息

Nuclear Medicine Department, François Baclesse Cancer Centre, Caen, France.

INSERM U1086 ANTICIPE, BioTICLA, Caen University, Caen, France.

出版信息

EJNMMI Phys. 2017 Dec;4(1):17. doi: 10.1186/s40658-017-0185-4. Epub 2017 May 30.

DOI:10.1186/s40658-017-0185-4
PMID:28560574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5449363/
Abstract

BACKGROUND

This study evaluates the consistency of PET evaluation response criteria in solid tumours (PERCIST) and European Organisation for Research and Treatment of Cancer (EORTC) classification across different reconstruction algorithms and whether aligning standardized uptake values (SUVs) to the European Association of Nuclear Medicine acquisition (EANM)/EARL standards provides more consistent response classification.

MATERIALS AND METHODS

Baseline () and response assessment () scans in 61 patients with non-small cell lung cancer were acquired in protocols compliant with the EANM guidelines and were reconstructed with point-spread function (PSF) or PSF + time-of-flight (TOF) reconstruction for optimal tumour detection and with a standardized ordered subset expectation maximization (OSEM) reconstruction known to fulfil EANM harmonizing standards. Patients were recruited in three centres. Following reconstruction, EQ.PET, a proprietary software solution was applied to the PSF ± TOF data (PSF ± TOF.EQ) to harmonize SUVs to the EANM standards. The impact of differing reconstructions on PERCIST and EORTC classification was evaluated using standardized uptake values corrected for lean body mass (SUL).

RESULTS

Using OSEM/OSEM (standard scenario), responders displayed a reduction of -57.5% ± 23.4 and -63.9% ± 22.4 for SUL and SUL, respectively, while progressing tumours had an increase of +63.4% ± 26.5 and +60.7% ± 19.6 for SUL and SUL respectively. The use of PSF ± TOF reconstruction impacted the classification of tumour response. For example, taking the OSEM/PSF ± TOF scenario reduced the apparent reduction in SUL in responding tumours (-39.7% ± 31.3 and -55.5% ± 26.3 for SUL and SUL, respectively) but increased the apparent increase in SUL in progressing tumours (+130.0% ± 50.7 and +91.1% ± 39.6 for SUL and SUL, respectively). Consequently, variation in reconstruction methodology (PSF ± TOF/OSEM or OSEM /PSF ± TOF) led, respectively, to 11/61 (18.0%) and 10/61 (16.4%) PERCIST classification discordances and to 17/61 (28.9%) and 19/61 (31.1%) EORTC classification discordances. An agreement was better for these scenarios with application of the propriety filter, with kappa values of 1.00 and 0.95 compared to 0.75 and 0.77 for PERCIST and kappa values of 0.93 and 0.95 compared to 0.61 and 0.55 for EORTC, respectively.

CONCLUSION

PERCIST classification is less sensitive to reconstruction algorithm-dependent variability than EORTC classification but harmonizing SULs within the EARL program is equally effective with either.

摘要

背景

本研究评估了实体瘤PET评估反应标准(PERCIST)与欧洲癌症研究与治疗组织(EORTC)分类在不同重建算法中的一致性,以及将标准化摄取值(SUV)与欧洲核医学协会采集(EANM)/EARL标准对齐是否能提供更一致的反应分类。

材料与方法

对61例非小细胞肺癌患者进行基线()和反应评估()扫描,扫描方案符合EANM指南,并采用点扩散函数(PSF)或PSF+飞行时间(TOF)重建以实现最佳肿瘤检测,同时采用已知符合EANM协调标准的标准化有序子集期望最大化(OSEM)重建。患者在三个中心招募。重建后,将专有软件解决方案EQ.PET应用于PSF±TOF数据(PSF±TOF.EQ),以使SUV符合EANM标准。使用校正瘦体重后的标准化摄取值(SUL)评估不同重建对PERCIST和EORTC分类的影响。

结果

使用OSEM/OSEM(标准方案)时,反应性肿瘤的SUL和SUL分别降低了-57.5%±23.4和-63.9%±22.4,而进展性肿瘤的SUL和SUL分别增加了+63.4%±26.5和+60.7%±19.6。PSF±TOF重建的使用影响了肿瘤反应的分类。例如,采用OSEM/PSF±TOF方案时,反应性肿瘤中SUL的明显降低减少了(SUL和SUL分别为-39.7%±31.3和-55.5%±26.3),但进展性肿瘤中SUL的明显增加增加了(SUL和SUL分别为+130.0%±50.7和+91.1%±39.6)。因此,重建方法的差异(PSF±TOF/OSEM或OSEM/PSF±TOF)分别导致11/61(18.0%)和10/61(16.4%)的PERCIST分类不一致,以及17/61(28.9%)和19/61(31.1%)的EORTC分类不一致。应用专有滤波器后,这些方案的一致性更好,PERCIST的kappa值分别为1.00和0.95,而之前为0.75和0.77;EORTC的kappa值分别为0.93和0.95,而之前为0.61和0.55。

结论

与EORTC分类相比,PERCIST分类对重建算法相关变异性的敏感性较低,但在EARL计划中使SUL标准化对两者同样有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/9ce8f65a320b/40658_2017_185_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/61a0977a43f8/40658_2017_185_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/d7424228afac/40658_2017_185_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/76dc33b9a63b/40658_2017_185_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/d4c29a71a5e5/40658_2017_185_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/9ce8f65a320b/40658_2017_185_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/61a0977a43f8/40658_2017_185_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/d7424228afac/40658_2017_185_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/76dc33b9a63b/40658_2017_185_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/d4c29a71a5e5/40658_2017_185_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc5/5449363/9ce8f65a320b/40658_2017_185_Fig5_HTML.jpg

相似文献

1
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.欧洲癌症研究与治疗组织(EORTC)的正电子发射断层扫描(PET)反应标准比实体瘤疗效评价标准(PERCIST)更容易受到重建不一致性的影响,但两者都受益于欧洲放射学会低剂量协议(EARL)协调计划。
EJNMMI Phys. 2017 Dec;4(1):17. doi: 10.1186/s40658-017-0185-4. Epub 2017 May 30.
2
Does PET SUV Harmonization Affect PERCIST Response Classification?PET SUV 匀和是否影响 PERCIST 应答分类?
J Nucl Med. 2016 Nov;57(11):1699-1706. doi: 10.2967/jnumed.115.171983. Epub 2016 Jun 9.
3
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.多中心试验中使用不同代 PET 系统时 SUV 的调和:非小细胞肺癌患者的前瞻性验证。
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):985-96. doi: 10.1007/s00259-013-2391-1. Epub 2013 Apr 6.
4
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.在保持最佳病灶检测的同时实现氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)定量的一致性:对517例肿瘤患者进行的前瞻性多中心验证
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82. doi: 10.1007/s00259-015-3128-0. Epub 2015 Jul 30.
5
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.在欧洲核医学协会(EANM)的EARL认证计划中生成标准化的SUV:软件方法与符合EARL标准的重建方法
Ann Nucl Med. 2017 Feb;31(2):125-134. doi: 10.1007/s12149-016-1135-2. Epub 2016 Nov 3.
6
Treatment response assessment in [F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol.[F]FDG-PET/CT 肿瘤扫描中的治疗反应评估:计数统计变化和重建方案的影响。
Phys Med. 2019 Jan;57:177-182. doi: 10.1016/j.ejmp.2018.12.038. Epub 2019 Jan 10.
7
SUV Harmonization Between Different Hybrid PET/CT Systems.不同混合 PET/CT 系统之间的 SUV 融合
Clin Nucl Med. 2018 Nov;43(11):811-814. doi: 10.1097/RLU.0000000000002284.
8
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.为何在使用 FDG PET/CT 作为预后指标时需要进行协调:符合 EARL 标准的 SUV 作为肺癌独立预后因素的验证。
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):421-428. doi: 10.1007/s00259-018-4151-8. Epub 2018 Sep 14.
9
Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs).EARL harmonization 程序对代谢活性肿瘤体积(MATV)自动勾画的影响。
EJNMMI Res. 2017 Dec;7(1):30. doi: 10.1186/s13550-017-0279-y. Epub 2017 Mar 31.
10
F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer.在标准化计划时代通过纹理特征进行F-FDG PET/CT异质性量化:以肺癌为重点
Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2324-2335. doi: 10.1007/s00259-016-3441-2. Epub 2016 Jun 21.

引用本文的文献

1
New FDG-PET/CT interpretation criteria (Huaxi criteria) for response assessment in patients with nasal-type extranodal NK/T-cell lymphoma: development and validation.鼻型结外NK/T细胞淋巴瘤患者疗效评估的新FDG-PET/CT解读标准(华西标准):制定与验证
Ann Hematol. 2025 Jun 3. doi: 10.1007/s00277-025-06420-z.
2
Optimization of Reconstruction Parameters for Discovery 710 Positron Emission Tomography/Computed Tomography.Discovery 710正电子发射断层扫描/计算机断层扫描重建参数的优化
J Med Phys. 2025 Jan-Mar;50(1):118-130. doi: 10.4103/jmp.jmp_167_24. Epub 2025 Feb 24.
3
High concordance of PET-CT treatment response evaluation according to PERCIST 1.0 when comparing images reconstructed with OSEM vs. BSREM.

本文引用的文献

1
EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.EANM/EARL在PET定量分析中的协调策略:从日常实践到多中心肿瘤学研究。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):17-31. doi: 10.1007/s00259-017-3740-2. Epub 2017 Jun 16.
2
Digital PET compliance to EARL accreditation specifications.数字正电子发射断层扫描符合EARL认证规范。
EJNMMI Phys. 2017 Dec;4(1):9. doi: 10.1186/s40658-017-0176-5. Epub 2017 Jan 31.
3
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
根据PERCIST 1.0标准,比较用有序子集期望最大化(OSEM)与基于模型的迭代重建(BSREM)重建的图像时,PET-CT治疗反应评估具有高度一致性。
Clin Physiol Funct Imaging. 2025 Jan;45(1):e12907. doi: 10.1111/cpf.12907. Epub 2024 Sep 20.
4
Metabolic Imaging of Advanced Basal Cell Carcinoma Treated with Sonidegib: A Retrospective Case Series Study.用索尼德吉治疗的晚期基底细胞癌的代谢成像:一项回顾性病例系列研究。
J Clin Med. 2024 Aug 27;13(17):5087. doi: 10.3390/jcm13175087.
5
The impact of introducing deep learning based [F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT.基于深度学习的[F]FDG PET去噪技术引入对数字PET/CT中EORTC和PERCIST治疗反应评估的影响
EJNMMI Res. 2024 Aug 10;14(1):72. doi: 10.1186/s13550-024-01128-z.
6
Harmonization of standard uptake values across different positron emission tomography/computed tomography systems and different reconstruction algorithms: validation in oncology patients.不同正电子发射断层扫描/计算机断层扫描系统及不同重建算法间标准摄取值的标准化:肿瘤患者中的验证
EJNMMI Phys. 2023 Mar 15;10(1):19. doi: 10.1186/s40658-023-00540-z.
7
A review of harmonization strategies for quantitative PET.定量 PET 调谐策略综述。
Ann Nucl Med. 2023 Feb;37(2):71-88. doi: 10.1007/s12149-022-01820-x. Epub 2023 Jan 6.
8
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.《EANM/SNMMI/ANZSNM 联合实践指南/程序标准:在实体瘤患者接受免疫调节治疗期间推荐使用 [F]FDG PET/CT 成像(第 1.0 版)》
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2323-2341. doi: 10.1007/s00259-022-05780-2. Epub 2022 Apr 4.
9
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.二十年回顾:实体瘤疗效评估标准(RECIST)作为实体瘤反应生物标志物——欧洲癌症研究与治疗组织(EORTC)影像组与欧洲肿瘤内科学会(ESOI)联合论文
Front Oncol. 2022 Jan 10;11:800547. doi: 10.3389/fonc.2021.800547. eCollection 2021.
10
Evaluation of the Accuracy of Standardized Uptake Values of F-fluorodeoxyglucose in Lung Lesions Based on Phantom Studies.基于体模研究的肺病变 F-氟脱氧葡萄糖标准化摄取值准确性评估。
Sovrem Tekhnologii Med. 2021;13(3):15-23. doi: 10.17691/stm2021.13.3.02. Epub 2021 Jun 28.
在欧洲核医学协会(EANM)的EARL认证计划中生成标准化的SUV:软件方法与符合EARL标准的重建方法
Ann Nucl Med. 2017 Feb;31(2):125-134. doi: 10.1007/s12149-016-1135-2. Epub 2016 Nov 3.
4
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.代谢肿瘤体积可预测在ACRIN 6668/RTOG 0235试验中接受治疗的III期非小细胞肺癌患者的总生存期和局部控制情况。
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):17-24. doi: 10.1007/s00259-016-3520-4. Epub 2016 Sep 19.
5
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.对于接受厄洛替尼治疗的转移性肺腺癌患者,TLG-S标准在预测预后方面优于EORTC和PERCIST。
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2155-2165. doi: 10.1007/s00259-016-3433-2. Epub 2016 Jun 3.
6
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.在非小细胞肺癌患者中,比较RECIST、EORTC标准和PERCIST用于评估化疗早期反应的情况。
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1945-53. doi: 10.1007/s00259-016-3420-7. Epub 2016 May 28.
7
The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST.分析的转移性乳腺癌病灶数量对使用PERCIST的18F-FDG PET/CT反应评估的影响
J Nucl Med. 2016 Jul;57(7):1102-4. doi: 10.2967/jnumed.115.166629. Epub 2016 Mar 16.
8
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.采用18F-FDG PET和PERCIST 1.0评估早期治疗反应可预测接受胰岛素样生长因子1受体单克隆抗体治疗的尤因肉瘤家族性肿瘤患者的生存情况。
J Nucl Med. 2016 May;57(5):735-40. doi: 10.2967/jnumed.115.162412. Epub 2016 Jan 21.
9
Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer.使用实体瘤疗效评价标准中基于正电子发射断层扫描的代谢反应标准(PERCIST)预测胰腺癌肝转移放射性栓塞术后的无进展生存期和总生存期。
J Nucl Med. 2016 Mar;57(3):355-60. doi: 10.2967/jnumed.115.165613. Epub 2015 Nov 25.
10
Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.PET/CT图像重建方法及肝脏摄取归一化策略对定量图像分析的影响
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):249-258. doi: 10.1007/s00259-015-3165-8. Epub 2015 Aug 18.